Lijie Zhai

4PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersIndustrial molecular engineering of nucleic acids and proteinsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 26, 2026
Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205.

|Sep 19, 2023
Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence.

Margaret Johnson, April Bell, Kristen L Lauing

|Sep 04, 2021
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma.

Lijie Zhai, April Bell, Erik Ladomersky

|Jun 18, 2020
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.

Erik Ladomersky, Lijie Zhai, Kristen L Lauing

Pageof 1